BHCM
NXTM

Brevan Howard Capital Management’s NxStage Medical Inc. NXTM Stock Holding History

Brevan Howard Capital Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$470K Buy
+17,016
New +$454K 1.08% 21

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Brevan Howard Capital Management's NXTM Position: Q3 2017 in Review

Brevan Howard Capital Management opened a new position in NxStage Medical Inc. (NXTM) in Q3 2017: 17,016 shares worth $470K. The stake represents 1.08% of the portfolio and ranks #21 among its holdings.

168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

  • Brevan Howard Capital Management held 17,016 shares of NxStage Medical Inc. worth $470K as of Q3 2017.
  • NxStage Medical Inc. was a new Brevan Howard Capital Management position in Q3 2017.
  • NxStage Medical Inc. made up 1.08% of Brevan Howard Capital Management's portfolio in Q3 2017, its #21 holding.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Brevan Howard Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.